Norges Bank
FLGT icon

Norges Bank’s Fulgent Genetics FLGT Stock Holding History

Norges Bank’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-85,358
Closed -$1.67M – 1877
2024
Q2 		$1.67M Sell
85,358
-23,744
-22% -$496K ﹤0.01% 1749
2024
Q1 		$2.37M Sell
109,102
-67,408
-38% -$1.67M ﹤0.01% 1723
2023
Q4 		$5.1M Sell
176,510
-31,300
-15% -$837K ﹤0.01% 1667
2023
Q3 		$5.56M Buy
207,810
+77,000
+59% +$2.63M ﹤0.01% 1656
2023
Q2 		$4.84M Buy
130,810
+25,100
+24% +$875K ﹤0.01% 1725
2023
Q1 		$3.3M Buy
105,710
+33,823
+47% +$1.09M ﹤0.01% 1845
2022
Q4 		$2.14M Buy
71,887
+17,200
+31% +$615K ﹤0.01% 1966
2022
Q3 		$2.08M Sell
54,687
-33,705
-38% -$1.69M ﹤0.01% 1910
2022
Q2 		$4.82M Sell
88,392
-45,107
-34% -$2.48M ﹤0.01% 1778
2022
Q1 		$8.33M Hold
133,499
– – ﹤0.01% 1757
2021
Q4 		$13.4M Buy
133,499
+25,894
+24% +$2.28M ﹤0.01% 1647
2021
Q3 		$9.68M Buy
+107,605
New +$9.78M ﹤0.01% 1776

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank's FLGT Position: Q3 2024 in Review

Norges Bank sold out of Fulgent Genetics (FLGT) in Q3 2024, closing a stake of 85,358 shares — an estimated $1.67M sold.

Norges Bank first reported a position in FLGT in Q3 2021 and held it in 12 quarters. The position peaked at $13.4M in Q4 2021. 183 funds tracked by Wall St. Rank hold FLGT as of Q3 2024.

  • Norges Bank reported no remaining Fulgent Genetics position as of Q3 2024 after selling out during the quarter.
  • Norges Bank sold 85,358 Fulgent Genetics shares in Q3 2024, an estimated $1.67M.
  • Norges Bank first reported a position in Fulgent Genetics in Q3 2021 and held it in 12 quarters.
  • Norges Bank's Fulgent Genetics position peaked at $13.4M in Q4 2021.
  • 183 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2024.

Based on Norges Bank's 13F filing for Q3 2024, filed 13 Nov 2024.